Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2020-01-10 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于提前归还部分暂时补充流动资金的募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the early repayment of part of the temporarily supplemented working capital from raised funds. It discusses the use and repayment of idle raised funds temporarily used for working capital, referencing previous board resolutions and disclosures. The document is short (940 characters) and primarily provides an update on capital usage and repayment, without containing financial statements or detailed financial analysis. This fits the description of a Capital/Financing Update (CAP) rather than a full financial report or other categories.
2020-01-10 Chinese
2019年第四季度可转换公司债券转股情况公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bonds (可转换公司债券) of 特一药业集团股份有限公司 for the fourth quarter of 2019. It details the bond issuance, conversion price adjustments, and the changes in shares due to bond conversions during the quarter. The document includes specific bond codes, conversion prices, regulatory approvals, and shareholding changes related to the convertible bonds. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about bond conversion and share changes. The document length is 2361 characters, which is relatively short and focused on a specific capital market event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as convertible bond conversions.
2020-01-02 Chinese
关于全资子公司完成工商登记并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business registration and obtaining a business license for a wholly-owned subsidiary. It includes details about the subsidiary's name, capital, type, establishment date, legal representative, and business scope. There is no financial data, no mention of financial results, no voting results, no management changes, no legal proceedings, and no regulatory certifications. The document is an official announcement about a corporate event (subsidiary registration) rather than a report or detailed filing. It fits best under Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2019-12-26 Chinese
关于第四届监事会第九次会议决议的公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a resolution passed at the ninth meeting of the fourth Supervisory Board of the company. It includes details about the meeting date, attendance, and the voting result on a proposal to invest in establishing a wholly-owned subsidiary. There is no financial data, no detailed report, and no mention of an annual or interim report. The document is a corporate governance announcement related to board or supervisory committee decisions. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so RPA is not appropriate.
2019-12-25 Chinese
关于第四届董事会第九次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the ninth meeting of the fourth board of directors of the company. It details the meeting date, attendance, and the approval of an investment proposal to establish a wholly-owned subsidiary. There is no financial data, audit information, or detailed report content. It is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and focused on board decisions, not a full report or regulatory filing.
2019-12-25 Chinese
关于公司签署项目合作合同的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 特一药业集团股份有限公司 about signing a project cooperation contract with 广滕医药（深圳）有限公司. It details the contract's content, parties involved, cooperation scope, and potential risks. The document explicitly states that the contract is a routine R&D cooperation and does not require board or shareholder approval. It also mentions that the contract will not have a significant impact on the company's 2019 financials. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal announcement of a contract signing rather than a financial report or management discussion. Therefore, it fits best under the category of a Regulatory Filing (RNS), which covers general regulatory announcements and disclosures that do not fit other specific categories.
2019-12-25 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.